Dissertations / Theses on the topic 'HBC'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'HBC.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Bitencourt, Hellen Tayaná Oliveira. "Pesquisa e caracterização da hepatite B oculta em doadores de sangue do estado do Amapá." Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/17/17155/tde-07062017-161019/.
Full textIntroduction. The infection caused by the hepatitis B virus (HBV) is one of the most prevalent diseases in the world. According to the World Health Organization (WHO) there are more than 350 million chronic carriers of the disease. HBV infection is routinely identified when there is presence of circulating HBsAg. However, in some cases HBV-DNA has been detected in HBsAg negative individuals, positive or negative for anti-HBc and anti-HBs. This serological and molecular presentation is termed HBV-occult infection (OBI). Usually the concentration of HBV-DNA in serum will be below 200 IU / mL.Objective: To determine the prevalence of OBI in blood donors, in the State of Amapá, in the 2014. Material and methods. A total of 62 samples of blood donors from the State of Amapá in the year 2014 were analyzed, presenting the serological profile: HBsAg negative, anti-HBc positive and with negative or positive anti-HBs. Serum markers HBsAg and anti-HBc were determined by the chemiluminescent immunoassay. Samples selected for HBV-DNA detection were tested using the Real-Time PCR Kit Kit HIV / HCV / HBV (Bio-Manguinhos®) and in-house PCR. Results. Of the total of 13,261 donors screened for blood-borne infections, 283 presented reactive results for hepatitis B markers, in which: 35 (0.3%) were HBsAg and 248 (1.9%) for anti-HBc reagents. All samples showed nondetectable HBV-DNA result. Conclusion: The serological disability index in the year 2014 in HEMOAP was 1.9% for anti-HBc and 0.3% for HBsAg. The studied population consisted predominantly of adults aged 29-65 years, males, married and natural of cities of the state of Amapá
BARROS, Emanuelle Antonino. "Pesquisa do HBV-DNA em doadores de sangue com diferentes perfis sorológicos para hepatite B." Universidade Federal de Pernambuco, 2010. https://repositorio.ufpe.br/handle/123456789/6990.
Full textTestes sorológicos para detecção do HBsAg e anti-HBc são realizados em doadores de sangue para evitar a transmissão da hepatite B. No entanto, a maior causa de rejeição nos hemocentros é a detecção do anti-HBc, que provoca ausência de doadores e descarte de bolsas de sangue, o que aumenta os custos nos bancos de sangue. Mas, pesquisas mostram que doadores anti-HBc positivo com ou sem o anti-HBs, podem continuar replicando o vírus e transmitir a infecção aos receptores dos hemocomponentes. Outros estudos mostram que doadores HBsAg/anti-HBc positivos na fase crônica podem conter quantidades de HBV-DNA muito baixas e não ser detectado por testes moleculares. Ainda existe um risco de transmissão que ocorre se o doador estiver na fase inicial da infecção, antes da detecção do HBsAg e que pode ser evitado pesquisando-se o HBV-DNA. Testes para detecção de ácidos nucleicos (NAT) do HIV, HCV e HBV em doadores de sangue já ocorre em alguns países, e no Brasil, está em fase de implantação para o HIV e HCV. Os objetivos deste estudo foram: pesquisar o HBV-DNA em doadores de sangue anti-HBc positivo da Fundação HEMOPE com e sem o anti-HBs, determinar a carga viral nos doadores HBsAg/anti-HBc positivo e estimar a frequência de positividade do HBV-DNA nos diferentes perfis sorológicos no período de junho de 2009 a fevereiro de 2010. Trezentos e vinte doadores anti-HBc/anti-HBs positivos, 39 HBsAg/anti-HBc positivos e 41 anti-HBc positivo isolado participaram do estudo. A pesquisa do HBV-DNA foi realizada pelo teste qualitativo de nested-PCR e a quantificação pelo teste AMPLICOR HBV MONITOR (ROCHE). Os resultados mostraram que o HBV-DNA não foi detectado em nenhum doador anti-HBc/anti-HBs positivos e anti-HBc positivo isolado, sendo quantificado em 64% dos HBsAg/anti-HBc positivos. Esses resultados sugerem que com a utilização de uma técnica mais sensível, aumentaria a possibilidade de se detectar o HBV-DNA em um número maior de doadores. Além disso, a substituição do teste do HBsAg pela detecção do HBV-DNA, requer cautela e novos estudos. No entanto, o HBV-DNA é um marcador útil para detectar a infecção na fase de janela imunológica
Indrák, Martin. "Komplexní zhodnocení finanční pozice podniku Coca Cola HBC Česká republika." Master's thesis, Vysoká škola ekonomická v Praze, 2008. http://www.nusl.cz/ntk/nusl-10561.
Full textKyselová, Karolina. "Podnikatelské strategie pro čínský trh - příklad společnosti Coca-Cola, HBC." Master's thesis, Vysoká škola ekonomická v Praze, 2011. http://www.nusl.cz/ntk/nusl-112677.
Full textSchwab, Anja. "Gestaltung flexibler Arbeitszeiten dargestellt am Beispiel der HBC-radiomatic GmbH /." [S.l. : s.n.], 2005. http://www.bsz-bw.de/cgi-bin/xvms.cgi?SWB11759405.
Full textLeturcq, Didier. "Purification de l'antigène de capside du virus de l'hépatite B (AG HBC) et préparation d'anticorps monoclonaux anti-HBC : application de ces deux réactifs en immuno-enzymologie." Tours, 1987. http://www.theses.fr/1987TOUR3802.
Full textInuzuka, Tadashi. "Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalence." Kyoto University, 2016. http://hdl.handle.net/2433/215419.
Full textMAGALHÃES, Paula Machado Ribeiro. "Perfil de produção de anticorpos após vacinação para Hepatite B em doadores sanguíneos positivos para Anti-HBc e negativos para HBsAg e Anti-HBs." Universidade Federal de Pernambuco, 2005. https://repositorio.ufpe.br/handle/123456789/7397.
Full textO anticorpo contra o antígeno do centro (ou do core), o anti-HBc, do vírus da hepatite B (VHB) é considerado o mais sensível e duradouro marcador sérico da infecção pelo VHB. Algumas vezes o anti-HBc é encontrado na ausência de outros marcadores como por exemplo o anti-HBs ou o HBsAg. O significado clínico do encontro isolado do anti-HBc permanece incerto. Existem algumas explicações para este achado: primeiro, o encontro do anti-HBc pode ser um resultado apenas falso-positivo. Segundo, o indivíduo pode ter ficado imune após contato com o VHB, porém não possui anti-HBs detectável. Terceiro, estes indivíduos com anti-HBc isolado podem ser portadores crônicos do VHB com ausência ou não detecção de HBsAg. Além do que o encontro isolado do anti-HBc pode ser pelo fato do indivíduo se encontrar na fase de janela imunológica quando o HBsAg desapareceu mas o anti-HBs ainda não está detectável. Uma última hipótese menos provável é que a presença do anti-HBc possa ter sido devida a uma passagem passiva deste anticorpo. Exceto a situação de janela imunológica todas as outras explicações hipotéticas teriam teoricamente esclarecimento com o uso de técnicas de biologia molecular. Porém, como é cara e laboriosa não é utilizada de rotina. Haja vista a importância tanto do ponto de vista do indivíduo como para os serviços de saúde de elucidar se o anti-HBc isolado é falso-positividade do teste ou contato prévio com o VHB alguns serviços de saúde têm utilizado a vacinação contra o VHB nestes indivíduos para distinguir entre estas duas situações. O objetivo deste estudo foi avaliar a resposta contra vacina recombinante para VHB em doadores sanguíneos portadores de anti-HBc e negativos para HBsAg e anti-HBs. O modelo do estudo foi do tipo quasi-experimental sem grupo controle, não randomizado. Vinte e quatro doadores entre 22 e 76 anos receberam três doses de 20 mcg de Engerix®-B nos meses 0, 1 e 6. Amostras sanguíneas foram coletadas 30 dias após primeira e terceira dose de vacina e testadas para anti-HBs pela técnica imunoenzimática por fluorescência. Os resultados mostraram que após a primeira e terceira dose de vacina a taxa de soroproteção (anti-HBs >10 miliUI/ml) foi de 61,9% e 87,5%, respectivamente. A taxa de resposta tipo anamnéstica com produção rápida de anticorpos foi de 38% e tipo primária ou lenta foi de 47,6%. A taxa de não respondedores ao final do esquema vacinal foi de 12,5%. Doadores estes potencialmente suspeitos de serem portadores inativos de VHB e que foram submetidos à pesquisa de DNA do VHB pela PCR sendo todos negativos para este teste. O uso da vacina recombinante contra VHB ajudou a elucidar a situação imunológica da maioria dos indivíduos do presente estudo. Portanto, a estratégia da vacinação parece ser prática e pouco laboriosa para esclarecimento diagnóstico neste grupo de doadores
Hertík, Vojtěch. "Analýza týmové práce vybraného pracovního týmu ve společnosti Coca-Cola HBC Česká republika, s.r.o." Master's thesis, Vysoká škola ekonomická v Praze, 2013. http://www.nusl.cz/ntk/nusl-198089.
Full textKupski, Carlos. "Perfil sorológico e molecular de indivíduos anti-HBc reagente e HBsAg negativo provenientes de um banco de sangue em uma área de baixa endemicidade para HBV." Pontifícia Universidade Católica do Rio Grande do Sul, 2005. http://hdl.handle.net/10923/4522.
Full textHepatitis B vírus (HBV), even after being eliminated, leaves serological markers which demonstrate a previous contact with the virus or an occult infection. Stages of HBV infection can be identified based on the profile of HBV markers. The aim of this study was to characterize the profile of serological and molecular HBV markers of individuals excluded from blood donation in a region of low HBV endemicity due to the presence of antibodies against hepatitis B core antigen (total anti-HBc), but negative for HBV surface antigen (HBsAg). A transversal study was designed to evaluate serological and molecular profile of subjects excluded from blood donation at the Blood bank of Hospital São Lucas -PUCRS (HSL-PUCRS), presenting a reagent total anti-HBc and negative HBsAg. From March 2003 to May 2005, 244 individuals were selected, all them exclusively total anti-HBc reagent, with all other serological markers routinely tested negative. Serological markers such HBsAg antibodies (anti-HBs), HBV “e” antigen (HBeAg), HBeAg antibodies (anti-HBe) were determined using the Elecsys commercial kits (Roche Diagnostics) and HBV-DNA was identified by polimerase chain reaction (PCR).Study was conducted with a total of 244 rejected blood samples, 85. 7% presenting anti-HBs titles 10 IU/L. Among 164 samples tested for serological markers related to viral replication, all were negative for HBeAg and 66. 5% were reagent for anti-HBe. All samples tested for HBV-DNA (n=241) were negative. Statistical analysis showed a significant association between anti-HBe and anti-HBs titles, where individuals with anti-HBe reagent were positively associated with strong protective anti-HBs titles (P=0,026). Based upon reported data, it is possible to conclude that study individuals from a low endemic area for HBV, excluded from blood donation due to an isolated reagent anti- HBc, have frequently shown anti-HBs titers which confer immunity against HBV, besides being negative for HBV-DNA.
O vírus da Hepatite B (HBV), mesmo depois de eliminado, deixa marcas sorológicas que podem demonstrar esse contato prévio ou infecção oculta. O perfil de marcadores permite identificar os diferentes estágios da infecção pelo HBV. O objetivo do presente estudo foi definir o perfil sorológico e molecular de indivíduos de uma área de baixa endemicidade para o HBV excluídos de doação de sangue por apresentarem anticorpos contra o antígeno do cerne do HBV (anti-HBc total), apesar de negativos para o antígeno de superfície do HBV (HBsAg). Um estudo transversal foi delineado para avaliar o perfil sorológico e molecular de indivíduos anti-HBc total reagente e HBsAg negativo impedidos da doação sangüínea no Banco de Sangue do HSL-PUCRS. No período de março/2003 a maio/2005 foram selecionados 244 indivíduos, todos apenas anti-HBc total reagente, com os demais marcadores rotineiramente testados negativos. As variáveis do estudo foram os seguintes marcadores: título de anticorpos contra o HBsAg (anti-HBs), antígeno “e” do HBV (HBeAg), anticorpos contra o HBeAg (anti-HBe) e HBV-DNA. Os marcadores sorológicos foram determinados utilizando kits comerciais Elecsys (Roche Diagnostics) e a pesquisa molecular de HBV foi realizada através da reação em cadeia de polimerase (PCR). A amostra do estudo foi composta por 244 impedimentos, sendo que 85,7% já apresentavam títulos de anti-HBs 10 UI/L. Em relação aos marcadores relacionados com a replicação viral, das 164 amostras testadas, todas foram HBeAg não-reagentes e 66,5% apresentavam anti-HBe reagente. Todas amostras testadas para o HBV-DNA (n=241) foram negativas. A análise estatística mostrou uma associação significativa entre anti-HBe e títulos de anti-HBs, onde os indivíduos anti-HBe reagente apresentaram uma associação positiva com títulos anti-HBs forte-protetores (P=0,026). A partir dos dados do presente estudo, é possível concluir que estes indivíduos de uma zona considerada de baixa endemicidade para o HBV, excluídos de doação sangüínea por apresentarem anti-HBc total reagente isolado, apresentaram, na maioria das vezes, títulos de anti-HBs que lhe conferem imunidade contra o HBV, além de não apresentarem HBV-DNA circulante.
Quioc-Salomon, Barbara. "Rôle de la protéine HBC du virus de l'hépatite B sur la biologie des ARN viraux." Thesis, Université de Paris (2019-....), 2019. https://theses.md.univ-paris-diderot.fr/QUIOC_SALOMON_Barbara_va.pdf.
Full textChronic HBV carriers (CHB) are at high risk of developing hepatocellular carcinoma. Because covalently closed circular DNA (cccDNA) persists in infected cells through RNA expression, deciphering the mechanisms involved in RNA transcription and stability is a crucial step to identify new antiviral targets. In addition to its role in capsid formation, HBV core protein (HBc) has been shown to be associated with the cccDNA and to modulate its structure, yet the impact of this modification on HBV transcription is not fully understood. To better understand the role of HBc in this context we constructed several mutants deficient for HBc expression. The first mutant has two stop codons after codon 27 in HBc followed by a substitution of the HBc sequence by a sequence encoding different epitopes. During infection, this virus shows a strong decrease in expression of viral RNA, which cannot be rescued by re-expression of HBc. The quantification of nascent RNAs shows that the defect appears to be post-transcriptional and is present as early as 2h after transcription. These results suggest that the observed defect is independent of HBc and that the deleted sequence in the HBV genome of this mutant could be involved in a post-transcriptional regulatory mechanism. With this mutant, we have been able to demonstrate that the HBc protein provided by the capsid during infection is able to re-associate onto the cccDNA in the nucleus. We then studied HBc mutants generated in the context of the the wild-type virus sequence, without the substitution. When expressed from a plasmid expressing both the genome and the HBc protein under the control of SV40 promoter, we observe a decrease of the pgRNA expression for mutants having the stop codons after the 27th or 38th codon of HBc, but not when the stop codon is located after the 67th codon. These results suggest that displacement of the HBc stop codon induces a decrease in pgRNA expression, independently of HBc protein, and that the natural stop codon of HBc could be protected from viral RNA surveillance pathways such as nonsense-mediated decay (NMD) that recognizes RNAs with a premature stop codon. During infections with these viruses, and therefore in the absence of HBc, we observed an increased in the defect for viruses having stop codons at position 27 and 38 and a defect appears for a virus having the stop codon at position 67. In this context, in the absence of HBc, we have seen that RNAs encoding surface proteins are also impacted and that RNA expression can be partially restored by HBc expression. By chromosome conformation capture techniques we were able to observe that the HBc-27* HBV virus is no longer excluded from repressed regions associated with lamins, indicating that the HBc protein could be involved in the localization of the cccDNA at active chromatin regions favorable for transcription.In order to understand the mechanisms involved in HBc regulation, we have isolated the nuclear partners of HBc and highlighted many factors involved in the RNA and DNA regulation, in the DNA damage repair and RNA processing.Overall, our results shed light on the regulatory mechanisms of HBV RNA biology
Masini, Filippo. "Coca cola hbc italia: Modello per il calcolo di inventory stock target e production cycles ottimali." Master's thesis, Alma Mater Studiorum - Università di Bologna, 2014. http://amslaurea.unibo.it/8060/.
Full textAi, Min. "Ordered mono- and multi-layers from nanographene derivatives." Doctoral thesis, Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2010. http://dx.doi.org/10.18452/16046.
Full textThis thesis reports on the investigation of self-assembled mono- and multilayers from nanographene derivatives via scanning tunneling microscopy (STM) at solid-liquid interfaces. Because of the unique electronic properties associated with their -bonded topology, nanographenes are promising building blocks for molecular and organic electronics, which provide the possibility of tunability together with low-cost processing, light weight, and flexibility. For the application in electronics it is necessary to organize nanographenes in ultrathin films with well-ordered supramolecular structures. Nanostructures of monolayers on Highly Oriented Pyrolytic Graphite (HOPG) are studied for different nanographene derivatives, such as alkylated hexa-peri-hexabenzocoronenes (HBCs) with different symmetries, and triangle-shaped polycyclic aromatic hydrocarbons (PAHs). They exhibit a surprising diversity of supramolecular structures, for example zigzag, flower-like or honeycomb shapes. A fascinating peculiarity provides the honeycomb structures which are self-assembled from triangle-shaped alkylated phenyl PAHs, which provide nanotemplates to accommodate guest molecules. In many cases, nanographene derivatives not only form monolayers but also multilayers on HOPG. Star-shaped HBC molecules self organize into bilayers in polar solvents, which exhibit the potential for the formation of building blocks of organic electronics, for instance nanowires. The alkylated phenyl HBCs form polycrystalline structures both in the “face-on” arrangement in a monolayer on HOPG, and “edge-on” in multilayers within an external electric field. Both may be useful for potential applications, since in a photovoltaic cell, the “face-on” orientation on surfaces is required, while for the purpose to be applied in organic field-effect transistors, the “edge-on” nanostructure on the electrodes is necessary.
Kupski, Carlos. "Perfil sorol?gico e molecular de indiv?duos anti-HBc reagente e HBsAg negativo provenientes de um banco de sangue em uma ?rea de baixa endemicidade para HBV." Pontif?cia Universidade Cat?lica do Rio Grande do Sul, 2005. http://tede2.pucrs.br/tede2/handle/tede/1665.
Full textO v?rus da Hepatite B (HBV), mesmo depois de eliminado, deixa marcas sorol?gicas que podem demonstrar esse contato pr?vio ou infec??o oculta. O perfil de marcadores permite identificar os diferentes est?gios da infec??o pelo HBV. O objetivo do presente estudo foi definir o perfil sorol?gico e molecular de indiv?duos de uma ?rea de baixa endemicidade para o HBV exclu?dos de doa??o de sangue por apresentarem anticorpos contra o ant?geno do cerne do HBV (anti-HBc total), apesar de negativos para o ant?geno de superf?cie do HBV (HBsAg). Um estudo transversal foi delineado para avaliar o perfil sorol?gico e molecular de indiv?duos anti-HBc total reagente e HBsAg negativo impedidos da doa??o sang??nea no Banco de Sangue do HSL-PUCRS. No per?odo de mar?o/2003 a maio/2005 foram selecionados 244 indiv?duos, todos apenas anti-HBc total reagente, com os demais marcadores rotineiramente testados negativos. As vari?veis do estudo foram os seguintes marcadores: t?tulo de anticorpos contra o HBsAg (anti-HBs), ant?geno e do HBV (HBeAg), anticorpos contra o HBeAg (anti-HBe) e HBV-DNA. Os marcadores sorol?gicos foram determinados utilizando kits comerciais Elecsys (Roche Diagnostics) e a pesquisa molecular de HBV foi realizada atrav?s da rea??o em cadeia de polimerase (PCR). A amostra do estudo foi composta por 244 impedimentos, sendo que 85,7% j? apresentavam t?tulos de anti-HBs 10 UI/L. Em rela??o aos marcadores relacionados com a replica??o viral, das 164 amostras testadas, todas foram HBeAg n?o-reagentes e 66,5% apresentavam anti-HBe reagente. Todas amostras testadas para o HBV-DNA (n=241) foram negativas. A an?lise estat?stica mostrou uma associa??o significativa entre anti-HBe e t?tulos de anti-HBs, onde os indiv?duos anti-HBe reagente apresentaram uma associa??o positiva com t?tulos anti-HBs forte-protetores (P=0,026). A partir dos dados do presente estudo, ? poss?vel concluir que estes indiv?duos de uma zona considerada de baixa endemicidade para o HBV, exclu?dos de doa??o sang??nea por apresentarem anti-HBc total reagente isolado, apresentaram, na maioria das vezes, t?tulos de anti-HBs que lhe conferem imunidade contra o HBV, al?m de n?o apresentarem HBV-DNA circulante.
TRINDADE, Erika Ketlem Gomes. "Desenvolvimento de nanoimunossensor para identificação de anticorpos contra o vírus da hepatite B." Universidade Federal de Pernambuco, 2015. https://repositorio.ufpe.br/handle/123456789/15423.
Full textMade available in DSpace on 2016-02-25T17:28:13Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) Dissertação versão correta_Erika Trindade.pdf: 2153375 bytes, checksum: 27828150a490aba6be042d8498b9068e (MD5) Previous issue date: 2015-02-26
FACEPE
A infecção com o Vírus da Hepatite B (HBV) é uma das principais causas de morbidade e mortalidade em todo o mundo. Estima-se que 350 milhões de pessoas no mundo têm infecção crônica pelo HBV, o que representa aproximadamente 5% da população mundial. Levando-se em conta que a transmissão do HBV ocorre principalmente pelas vias parenteral e sexual, bolsas de sangue devem ser rigorosamente controladas. Um teste rápido antes da doação para identificar o marcador do HBV é desejável para reduzir os custos com o descarte desnecessário de bolsas de sangue. Atualmente, os anticorpos produzidos contra os antígenos do core do vírus da hepatite B (anti-HBc IgG) têm sido relatados como o marcador mais prevalente para o HBV devido a persistir por toda a vida e indicam infecção passada. Imunossensores são dispositivos analíticos que utilizam antígenos ou anticorpos e um transdutor para detecção rápida e quantificação de analitos e também podem ser portáteis. Diferentes tipos de transdutores para imunossensores são utilizados, tais como eletroquímico, óptico e piezoeléctrico. As técnicas eletroquímicas têm como princípio básico a detecção de espécies eletroativas presentes no processo de interação do elemento biológico com o transdutor. Transdutores eletroquímicos amperométricos estão entre os mais utilizados, devido à sua facilidade para portabilização. Os nanomateriais e os polímeros funcionalizados têm atraído grande interesse no desenvolvimento de matrizes de imobilização para biossensores devido a proporcionarem maior estabilidade e maior área para ancoramento de biomoléculas. Quando os nanotubos de carbono carboxilados são associados com politiramina, eles formam ligações amida que permitem que esta superfície seja muito mais estável, aumentando a precisão analítica. Este trabalho teve como objetivo o desenvolvimento de um imunossensor para detecção do anti-HBc através da imobilização do antígeno do HBc (HBcAg) em um eletrodo de ouro nanoestruturado formado por nanotubos de carbono carboxilados e politiramina. As modificações no eletrodo foram acompanhadas por voltametria cíclica e voltametria de onda quadrada. Foi obtida uma matriz estável, com processo de interação reversível e com possibilidade de portabilização. A faixa linear de resposta foi de 1,0 a 5,0 ng/mL, com limite inferior de detecção de 0,1ng/mL, mostrando grande sensibilidade para o anticorpo. Para uso clínico, o protótipo precisa ser validado em mais amostras sorológicas.
Infection with Hepatitis B Virus (HBV) is a major cause of morbidity and mortality worldwide. An estimated 350 million people have chronic HBV infection, which represents approximately 5% of the world population. Taking into account that transmission of HBV occurs mostly by via parenteral and sexual, blood bags should be tightly controlled. A quick test before donating to identify the marker of HBV is desirable to reduce unnecessary costs to dispose of blood bags. Currently, antibodies against the core antigen of hepatitis B (anti-HBc IgG) have been reported as the most prevalent marker for HBV virus due to persist throughout life, indicating past infection. Immunosensors are analytical devices that use antigens or antibodies, and a transducer for rapid detection and quantification of analytes and can also be portable. Different types of transducers for immunosensors are used, such as electrochemical, optical and piezoelectric. Electrochemical techniques have as basic principle the detection of electroactive species present in the interaction process of the biological element with the transducer. Amperometric electrochemical transducers are among the most widely used due to be easily portabilized. And nanomaterials functionalized polymers have attracted great interest in the development of immobilization matrices for biosensors owing to provide greater stability and larger area for biomolecule anchoring. When the carboxylated carbon nanotubes are associated with polytyramine they form amide bonds that allow the surface to be much more stable, enhancing the analytical precision. This work aimed at the development of an immunosensor for the detection of anti-HBc by immobilizing the HBc antigen (HBcAg) in a nanostructured gold electrode formed by carboxylated carbon nanotubes and polytyramine. The changes in the electrode were followed by cyclic voltammetry and square wave voltammetry. A stable matrix was obtained, with reversible interaction process and the possibility of portabilization. The linear response range was 1.0 to 5.0 ng/ml, with a lower detection limit of 0.1 ng/mL, showing great sensitivity to the antibody. For clinical use, the prototype must be validated in more serum samples.
Traoré, Aïcha Nina. "Mesure de l'incidence de l'hépatite virale B selon la séroconversion pour l'AC HBC, chez les donneurs de sang du Québec." Québec : Université Laval, 2007. http://www.theses.ulaval.ca/2006/24027/24027.pdf.
Full textTraoré, Aïcha Nina. "Mesure de l'incidence de l'hépatite virale B selon la séroconversion pour l'AC HBC, chez les donneurs de sang du Québec." Thesis, Université Laval, 2006. http://www.theses.ulaval.ca/2006/24027/24027.pdf.
Full textThe goal of this study was to evaluate the residual risk of hepatitis B viral (HBV) by measuring its incidence among 112,242 blood donors at Hema-Quebec, via the seroconversion for the antibody directed against the core (anti-HBc) instead of the usual surface antigen (HBsAg). We considered as incident cases donors who had a seroconversion for the anti-HBc and who were screened positive for the anti-HBs (antibody directed against the HBsAg). From April 2003 to April 2005, the identification of 13 anti-HBc incident cases and 3 for HBsAg permitted us to estimate respective incidences of 12.6 x 105 person-years-1 and 3.35 x 105 person-years-1, which corresponded to residual risks of 1 in 63,018 donations and 1 in 237,731 donations. The HBV incidence via the anti-HBc seroconversion is different from the estimate via the HBsAg. Our study suggests that anti-HBc seroconversion may not be a reliable marker of recent hepatitis B infection.
Traoré, Aïcha Nina. "Mesure de l'incidence de l'hépatite virale B selon la séroconversion pour l'AC HBC, chez les donneurs de sang du Québec." Master's thesis, Université Laval, 2007. http://hdl.handle.net/20.500.11794/18875.
Full textThe goal of this study was to evaluate the residual risk of hepatitis B viral (HBV) by measuring its incidence among 112,242 blood donors at Hema-Quebec, via the seroconversion for the antibody directed against the core (anti-HBc) instead of the usual surface antigen (HBsAg). We considered as incident cases donors who had a seroconversion for the anti-HBc and who were screened positive for the anti-HBs (antibody directed against the HBsAg). From April 2003 to April 2005, the identification of 13 anti-HBc incident cases and 3 for HBsAg permitted us to estimate respective incidences of 12.6 x 105 person-years-1 and 3.35 x 105 person-years-1, which corresponded to residual risks of 1 in 63,018 donations and 1 in 237,731 donations. The HBV incidence via the anti-HBc seroconversion is different from the estimate via the HBsAg. Our study suggests that anti-HBc seroconversion may not be a reliable marker of recent hepatitis B infection.
Schmitz-Hübsch, Thomas. "Von der organischen Heteroepitaxie zu organisch-organischen Heterostrukturen." Doctoral thesis, Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2003. http://nbn-resolving.de/urn:nbn:de:swb:14-1070465405156-18243.
Full textBeaudry, Jeanette T. "Effect of hemoglobins S and C on the in vivo expression and immune recognition of Plasmodium falciparum erythrocyte membrane protein 1 variants in Malian children." Thesis, University of Oxford, 2012. http://ora.ox.ac.uk/objects/uuid:21f27887-e7e8-4480-a8e4-c7072f3b392c.
Full textVentura, Maria Heloiza Torres. "Prevalência de anticorpos para hepatites virais B e C em estudantes de ensino fundamental da rede municipal da cidade de Santos-SP - 2008." Universidade Católica de Santos, 2009. http://biblioteca.unisantos.br:8181/handle/tede/567.
Full textEste estudo epidemiológico foi realizado com o objetivo de definir a soroprevalência das hepatites virais B e C em escolares que freqüentavam regularmente as escolas municipais de Ensino Fundamental no município de Santos, no período de novembro de 2008 a março de 2009,. Foram analisadas 98 amostras de sangue de escolares com idade entre 4 e 14 anos, através da técnica de ELISA, para detecção da presença de anticorpos anti-HVC, anti-HBc anti-HBs e HBsAg, Setenta e duas amostras foram positivas para a detecção do anti-HBs, mostrando uma eficácia na vacinação contra hepatite B de 75%. Em duas crianças foi detectada a presença do HVC, demonstrando uma prevalência de 2,8%. A pesquisa do anti-HBc foi positiva em duas crianças (prevalência de 2,8%) e o HBs-Ag foi detectado em uma criança (prevalência de 1,3%).
Khodl, Vojtěch. "Trade marketing." Master's thesis, Vysoká škola ekonomická v Praze, 2013. http://www.nusl.cz/ntk/nusl-192695.
Full textVajravelu, Dilip Kumar. "Connected Me - Proof of Concept." Thesis, Linköpings universitet, Elektroniksystem, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-100155.
Full textConnected Me
Akhiwu, Patrick. "Home Based Care (HBC) providers knowledge attitude and perception of identification treatment and referrals of common symptoms of Acquired Immune Deficiency Syndrome (AIDS) in Botswana." Master's thesis, University of Cape Town, 2016. http://hdl.handle.net/11427/20352.
Full textAssis, Jaqueline Calça. "Prevalência de anti-HBc isolado em amostras do instituto Adolfo Lutz e hepatite B oculta após resposta vacinal em pacientes do ambulatório municipal de hepatites virais." Faculdade de Medicina de São José do Rio Preto, 2016. http://hdl.handle.net/tede/422.
Full textMade available in DSpace on 2018-10-19T20:56:33Z (GMT). No. of bitstreams: 1 JaquelineCalçaAssis_dissert.pdf: 1656909 bytes, checksum: 0f9e5425c7d3ffa51b86c71d5b4b9687 (MD5) Previous issue date: 2016-11-07
The presence of anti-HBc alone can have several meanings: false positive, healing immune window, delayed immunity or occult hepatitis B virus infection (OBI). In clinical practice, it is important and necessary to clarify the diagnosis to prevent transmission to the risk population such as hemodialysis patients, blood donors, transplant recipients and co-infected individuals with HIV and/or HCV. Objectives: The aim of the study was to determine the prevalence of anti-HBc alone and occult hepatitis B, respectively, in blood samples from Adolfo Lutz Institute - Regional Laboratory Center X - São José do Rio Preto (IAL - CLR X - SJRP) and patients from Municipal Ambulatory of Viral Hepatitis (AMHV) both from São José do Rio Preto city in the period from January 1st, 2009 to December 31st, 2014. Methods: The study population of IAL - CLR X - SJRP is from the region served by the 15th Health Regional Division (DRS), and the AMHV is a population screened for clarification, monitoring and treatment of viral hepatitis in the city. In this population with anti-HBc alone, patients were immunized against hepatitis B and the individuals without vaccine response were selected for the performance of HBV-DNA research for the diagnosis of occult hepatitis B. Results: During the study period, 6805 samples were evaluated without duplication in IAL - CLR X - SJRP, of these 624 samples had anti-HBc positive, and the prevalence of anti-HBc alone was 17.63% (110/624). In the AMHV, 940 patients anti-HBc isolated were evaluated, from these 816 (86.81%) were vaccinated and after the criterion of disregarding the vaccinated patients who did not have anti-HBs evaluated after vaccination (85 - 10.42%), 731 (89.58%) patients were considered for analysis of the vaccine response, and 568 (77.70%) presented seroconversion with anti-HBs positive and 163 (22.30%) non-seroconverted patients. The research of HBV-DNA was performed in 25.77% (42/163) patients without a vaccine response, finding a prevalence of occult hepatitis B (OBI) of 47.62% (20/42).The presence of antibodies to HIV and HCV was 25.40% and 13.25% in the blood samples IAL - CLR X - SJRP and in AMHV was 1.80% and 0.33%, respectively. Conclusion: The results show the occurrence of antiHBc alone in IAL - CLR X - SJRP and the need of monitoring this population. In AMHV, the vaccination was effective for most cases, which demonstrates the need of vaccine introduction as a routine in anti- HBc alone patients in the overall population. The occult hepatitis B was found in almost half of patients assessed without vaccine response.
A presença do anti-HBc isolado pode ter vários significados: falso positivo, janela imunológica de cura, imunidade tardia ou infecção oculta pelo vírus da hepatite B (IOB). Na prática clínica é importante e necessário o esclarecimento diagnóstico para evitar transmissão em populações de risco como pacientes hemodialisados, doadores de sangue, transplantados e indivíduos coinfectados com HIV e/ou HCV. Objetivo: O objetivo do estudo foi determinar a prevalência de anti-HBc isolado e hepatite B oculta, respectivamente, em amostras de sangue do Instituto Adolfo Lutz - Centro de Laboratório Regional X - São José do Rio Preto (IAL - CLR X - SJRP) e pacientes do Ambulatório Municipal de Hepatites Virais (AMHV) ambos da cidade de São José do Rio Preto, no período de 01 de janeiro de 2009 a 31 de dezembro de 2014. Casuística e Métodos: A população estudada do IAL - CLR X - SJRP é proveniente da região atendida pela Divisão Regional de Saúde (DRS) XV e a do AMHV é uma população triada para esclarecimento, acompanhamento e tratamento das hepatites virais do município. Nesta população com anti-HBc isolado os pacientes foram imunizados contra hepatite B e os indivíduos sem resposta vacinal foram selecionados para realização da pesquisa de HBV-DNA para diagnóstico da hepatite B oculta. Resultados: Durante o período de estudo, foram avaliadas 6805 amostras, sem duplicação, no IAL - CLR X - SJRP, destas, 624 amostras apresentavam anti-HBc reagente, sendo a prevalência de anti-HBc isolado 17,63% (110/624). No AMHV foram analisados 940 pacientes com anti-HBc total isolado destes 816 (86,81%) foram vacinados e depois de aplicado o critério de desconsiderar os pacientes vacinados que não tiveram o anti-HBs avaliado após a vacinação (85 - 10,42%), 731 (89,58%) pacientes foram considerados para análise da resposta vacinal, sendo que 568 (77,70%) apresentaram soroconversão com anti-HBs positivo e 163 (22,30%) pacientes não soroconverteram. A pesquisa do HBV-DNA foi realizada em 25,77% (42/163) dos pacientes sem resposta vacinal, encontrando uma prevalência de hepatite B oculta (IOB) de 47,62% (20/42). A presença de anticorpos contra HIV e HCV foi de 25,40%, 13,25% nas amostras do IAL - CLR X - SJRP e no AMHV foi de 1,80%, 0,33%, respectivamente. Conclusão: Os resultados obtidos demonstram a ocorrência de anti-HBc isolado nas amostras do IAL - CLRX - SJRP e a necessidade de acompanhamento dessa população. No AMHV a vacinação esclareceu a maioria dos casos, o que demonstra a necessidade da introdução da vacina como rotina em pacientes anti-HBc isolado na população geral. A hepatite B oculta foi encontrada em quase metade dos pacientes não respondedores vacinais avaliados.
Pereira, Josiane Silveira Felix. "Avaliação sorologica e molecular de individuos isoladamente reagentes para anticorpos anti-HBc com e sem infecção oculta pelo virus B apos vacinação contra a hepatite B." [s.n.], 2004. http://repositorio.unicamp.br/jspui/handle/REPOSIP/313585.
Full textTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-04T11:37:13Z (GMT). No. of bitstreams: 1 Pereira_JosianeSilveiraFelix_D.pdf: 10131136 bytes, checksum: ab351928cb803d0e20ef10f92513bc45 (MD5) Previous issue date: 2004
Resumo: A elevada porcentagem de positividade para o anti-HBc pode resultar em excessiva perda de doadores em uma determinada região geográfica, podendo afetar o suprimento de sangue. Como a realização do anti-HBc foi introduzida nos bancos de sangue como marcador indireto da hepatite C, que hoje possui um teste específico, passou-se a questionar a necessidade dessa obrigatoriedade. Alguns estudos mostram a correlação entre a presença de anti-HBc no doador e infecção pelo VHB no receptor. Recentemente, com o desenvolvimento de técnicas de biologia molecular, tomou-se possível a determinação do DNA do VHB, que de certa maneira auxilia a investigação dos pacientes anti-HBc isoladamente reagentes. Como os pacientes anti-HBc reagentes podem apresentar infecção oculta pelo VHB, procuramos avaliar a ocorrência da mesma nos nossos doadores e por existir um potencial de transmissão do VHB procuramos avaliar se a vacinação seria capaz de levar os pacientes com DNA-VHB positivo a eliminar esse VHB residual, pois podem soroconverter quando recebem a vacina contra a hepatite B. Essa conduta poderia ser usada para diminuir a transmissão do VHB em áreas altamente endêmicas. Sabe-se também que a infecção oculta pelo VHB ocorre em altas freqüências entre pacientes com HVC crônica. Por isso avaliamos também uma amostra com esses pacientes. Ao final, comparamos os resultados das prevalências de infecção oculta pelo VHB, de soroconversão para o anti-HBs e de negativação do DNA-VHB, em grupos com diferentes graus de risco para aquisição da HVB. Neste trabalho foram avaliados 587 doadores de sangue provenientes do Hemocentro Campinas bloqueados na triagem de sangue do serviço de hemoterapia por apresentarem positividade para o anti-HBc quando da primeira doação de sangue. Todos eram negativos para o anti-HCV e anti-HIV. Foram identificados, responderam a um questionário específico e tiveram amostras de sangue coletadas para a realização de testes bioquímicos, uma nova pesquisa dos marcadores da hepatite B e uma pesquisa do DNA do VHB pela PCR. Convocamos os pacientes com o resultado anti-HBc reagente/anti-HBs não reagente a retomarem ao Ambulatório para serem vacinados Ao final, obtivemos três grupamentos: um de doadores de sangue anti-HBc não reagente, provavelmente falso-positivos (grupo A); um constituído por doadores de sangue anti-HBc reagentes/anti-HBs reagentes (grupo B); e outro por doadores de sangue anti-HBc reagente/anti-HBs não reagente (grupo C). Nestes foi realizada a pesquisa do DNA do VHB utilizando o soro da primeira coleta pela técnica da PCR "in house". As amostras positivas foram submetidas a nova pesquisa quantitativa do DNA-VHB com o teste Amplicor HBV Monitor (Roche Diagnostic Systems, Branchburg, NJ). Em 50 pacientes do grupo B, também foi realizada a pesquisa do DNA do VHB pela PCR "in house". Quando do retomo dos pacientes do grupo C, fazíamos a primeira dose (DI) da vacina Engerix B 'MARCA REGISTRADA¿. Na época da segunda dose (D2) da vacina, cerca de 30 dias após DI, e da terceira dose (D3), cerca de 5 meses após D2 coletávamos nova amostra de sangue para a realização de novas pesquisas do anti-HBs e do DNA-VHB. Foi selecionado também um grupo HBsAg negativo, anti-HBc reagente/anti-HBs não reagente/HCV reagente, constituído por 50 pacientes. 22 deles (10 DNA-VHB + e 12 DNA-VHB -) receberam as três doses da vacina e pesquisou-se a soroconversão e a negativação do DNA-VHB (grupo D). Para efeito de comparação com o grupo D, selecionamos um grupo de 26 pacientes HBsAg negativo/anti-HBc não reagentes/HCV reagentes (grupo E)... Observação: O resumo, na íntegra, poderá ser visualizado no texto completo da tese digital
Abstract: A high percentage of positivity for anti-HBc can result in excessive loss of donors in some geographic regions, and consequently could affect blood supplies. As anti-HBc testing was originally implemented in blood banks as an indirect marker of hepatitis C, which now has a specific test, there are now questions about the necessity for including this test. Some studies have shown a correlation between anti-HBc in the donor and infection with HBV in the receptor. Recently, with the advent of molecular biology techniques, it has become possible to detect HBV DNA, which can help in the investigation of patients that are anti-HBc reactive alone. Since anti-HBc reactive patients can present occult infection with HBV, we decided to evaluate the occurrence of this condition in our blood donors. As there individuaIs with anti-HBc alone can potentially transmit HBV, we evaluated via PCR if vaccination is capable of eliminating this residual HBV in patients who are HBV-DNA positive, as they can seroconvert when they are vaccinated against hepatitis B. This could be a strategy to reduce the transmission of HBV in highly endemic areas. It is also known that occult infection with HBV occurs at high frequencies among patients with chronic HCV. Consequently, we also evaluated a cohort of these patients. Finally, we compared the results on prevalence of occult infection with HBV, seroconversion to anti-HBs, and negativation of HBV-DNA, in groups with different degrees of risk for acquiring HBV. We made an ambulatory study of 587 blood donors attended at the Campinas Blood Center, who were rejected by blood screening as they were positive for anti-HBc at the time of the first donation. All of them were negative for anti-HCV and anti-HlV. In this first stage of the study, the blood donors were identified and they responded to a specific questionnaire. Also, on the day of the first visit, blood samples were collected to make biochemical tests, to retest for hepatitis B markers and investigation of HBV DNA with PCR. We had three groups; there was a group ofblood donors who were anti-HBc non-reactive, based on the new tests done at our service. These were probably false positives (group A). Group B was constituted of individuaIs who were anti-HBc reactive /anti-HBs reactive. Group C was constituted of blood donors who were anti-HBc reactive /anti HBs non-reactive. An investigation for HBV DNA was done on these individuaIs, using serum from the first blood collection, via "in house" PCR. The samples that were positive were then evaluated quantitatively for HBV DNA, using a commercial test (Amplicor HBV Monitor, Roche Diagnostic Systems, Branchburg, NJ). HBV DNA was also tested for in 50 randomly selected group B patients, via "in house" PCR. When the group C patients returned, we gave them the first dose (D1) of the vaccine Engerix B 'MARCA REGISTRADA¿. At the time of the second dose (D2) of vaccine, about 30 days after DI, we took another blood sample to test again for anti-HBs and for HBV DNA. The patients who seroconverted after DI did receive additional doses of vaccine. The second dose was administered approximateIy one month after DI and a third dose (D3), five months after D2. Another group of 50 HBsAg negative, anti-HBc reactive /anti-HBs non reactive /HCV reactive patients was also included in the study, to investigate if there was occult infection with hepatitis B vírus. Among these 50, 22 patients (10 HBV DNA + e 12 HBV DNA - ) were vaccinated for hepatitis B, and seroconversion and negativation of HBV-DNA were then investigated. These patients were given the three doses of vaccine (group D). For comparison with group D, we selected a group of 26 patients HbsAg negative/anti-HBc non-reactive /HCV reactive, who were also being studied in our ambulatory clinic (group E)... Note: The complete abstract is available with the full electronic digital thesis or dissertations
Doutorado
Ciencias Basicas
Doutor em Clínica Médica
Adomavicius, Tomas. "Evaluation of the hepatitis B virus particle as a malaria vaccine carrier." Thesis, University of Manchester, 2015. https://www.research.manchester.ac.uk/portal/en/theses/evaluation-of-the-hepatitis-b-virus-particle-as-a-malaria-vaccine-carrier(bb9e157f-dc5c-4b81-9731-5ced1cbef8fe).html.
Full textBotelho, Maria Aparecida de Oliveira. "Prevalência da soropositividade dos marcadores de hepatite B (HBsAG e ANTI-HBc) em gestantes do programa de proteção à gestante de Mato Grosso do Sul, 2004 a 2007." reponame:Repositório Institucional da UnB, 2008. http://repositorio.unb.br/handle/10482/5232.
Full textSubmitted by Jaqueline Ferreira de Souza (jaquefs.braz@gmail.com) on 2009-10-05T20:32:16Z No. of bitstreams: 1 2008_MariaAparecidaOliveiraBotelho.pdf: 1927243 bytes, checksum: 3fcd2ad3d04cb63e37cbcb246d238167 (MD5)
Approved for entry into archive by Gomes Neide(nagomes2005@gmail.com) on 2010-07-13T20:07:04Z (GMT) No. of bitstreams: 1 2008_MariaAparecidaOliveiraBotelho.pdf: 1927243 bytes, checksum: 3fcd2ad3d04cb63e37cbcb246d238167 (MD5)
Made available in DSpace on 2010-07-13T20:07:04Z (GMT). No. of bitstreams: 1 2008_MariaAparecidaOliveiraBotelho.pdf: 1927243 bytes, checksum: 3fcd2ad3d04cb63e37cbcb246d238167 (MD5) Previous issue date: 2008
As doenças infecciosas e parasitárias são responsáveis por um grande número de óbitos de mulheres em idade fértil. A hepatite B é uma doença infecto contagiosa, e um grave problema de saúde pública, sendo seu diagnóstico em gestantes importante para acompanhamento, tratamento e prevenção da transmissão vertical. O objetivo deste estudo foi determinar a prevalência da positividade de marcadores para hepatite B (HBsAg e Anti HBc), das gestantes acompanhadas pelo Programa de Proteção à Gestante do Estado de Mato Grosso do Sul (PPG) de 2004 a 2007, de acordo com a faixa etária e a procedência das gestantes. Foi feito um estudo descritivo, quantitativo, com coleta retrospectiva de dados. Os dados foram obtidos do banco de dados do PPG. Foram analisados os dados de 119.774 gestantes que participaram do PPG no período de março de 2004 a março de 2007, considerando a idade e a procedência das gestantes. A análise estatística dos dados foi feita utilizando o teste Qui-quadrado (χ2), com 95% de confiabilidade. Foram obtidos os seguintes resultados: Do total de gestantes analisadas, foram encontrados 347 casos positivos (uma média de 0,29%) para o HBsAg, e 773 casos positivos (média de 0,65%) para o anti-HBc. A análise espacial mostrou uma prevalência mais elevada para os dois marcadores, nas microrregiões de Iguatemi e Alto Taquari. Com relação a faixa etária, os resultados foram semelhantes para o HBsAg e anti-HBc, com prevalência maior em gestantes acima de 35 anos. Estes resultados revelam que a prevalência do vírus da hepatite B, foi inferior ao relatado pelo Ministério da Saúde para o estado de Mato Grosso do Sul e também quando comparado a alguns trabalhos disponíveis na literatura. ________________________________________________________________________________________ ABSTRACT
The infectious and parasitic diseases are responsible for a large number of deaths of women in fertile age. Hepatitis B is a contagious infectious disease, and a serious public health problem, therefore its diagnosis in pregnant women is important for the monitoring of these women and prevention of vertical transmission. The purpose of this study was to determine the prevalence of positivity of markers for hepatitis B (HBsAg and anti HBc), of the pregnant women who were attended by Pregnancy Protection Program of the state of Mato Grosso do Sul (PPG) between 2004 and 2007, according the age-groups and origin of the pregnant women. It was made a descriptive and quantitative study, with retrospective data collection. The data were obtained from the database of PPG. Were analyzed data from 119,774 women who had participated of the PPG between March 2004 and March 2007, considering the age and origin of the pregnant women. Statistical analysis of the data was made using the Chi-square (χ2), with 95% confidence. They were found the following results: Of the total number of pregnant women tested, 347 were found positive cases for HBsAg (average of 0.29%), and 773 positive cases for anti-HBc (average of 0.65%). The spatial analysis showed a higher prevalence to both markers in the micro region Iguatemi and Alto Taquari. In relation the age, the results were similar to the HBsAg and also for anti-HBc, with greater prevalence in pregnant women over 35 years. These results show that the prevalence of hepatitis B virus, was lower than that reported by the Health Department for the state of Mato Grosso do Sul and also when compared to some studies available in literature.
Maldari, Mirko. "Design of an ultra-low-power communication system for leadless pacemaker synchronization." Thesis, Institut polytechnique de Paris, 2020. http://www.theses.fr/2020IPPAT018.
Full textOur research focused on power optimized solutions for the communication between Leadless Cardiac Pacemakers (LCP) to allow a synchronized therapy among devices implanted in different cardiac chambers. A promising solution is the Intra-Body Communication (IBC), which uses biological tissues as transmission medium. The attenuation of the communication channels were characterized using an accurate torso model that has been verified by means of in-vivo experiments. An ultra-low power receiver has been designed in CMOS technology according to the sensitivity requirement coming from the intra-cardiac channel characterization. Moreover, a novel communication strategy has been proposed to minimize the power consumption of the receiver reducing the impact in terms of device longevity. The research results show the feasibility of a telemetry driven synchronization of LCPs, paving the way toward multiple-leadless pacemaker systems that might improve the quality of treatment of the bradycardia patients. This work was part of the WiBEC project. It is a multi-disciplinary project aiming to develop the wireless technologies for novel implantable devices
Forker, Roman. "Electronic Coupling Effects and Charge Transfer between Organic Molecules and Metal Surfaces." Doctoral thesis, Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2010. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-26163.
Full textZur Analyse der Struktur-Eigenschafts-Beziehungen dünner, epitaktischer Molekülfilme wird in situ differentielle Reflexionsspektroskopie (DRS) als Variante der optischen Absorptionsspektroskopie verwendet. Klare Zusammenhänge zwischen den Spektren und der unterschiedlich starken Kopplung zum jeweiligen Substrat werden gefunden. Während man breite und beinahe unstrukturierte Spektren für eine Quaterrylen (QT) Monolage auf Au(111) erhält, ist die spektrale Form von auf Graphit abgeschiedenem QT ähnlich der isolierter Moleküle. Durch Einfügen einer atomar dünnen organischen Zwischenschicht bestehend aus Hexa-peri-hexabenzocoronen (HBC) mit einem deutlich unterschiedlichen elektronischen Verhalten gelingt sogar eine effiziente elektronische Entkopplung vom darunter liegenden Au(111). Diese Ergebnisse werden durch systematische Variation der Metallsubstrate (Au, Ag und Al), welche von inert bis sehr reaktiv reichen, untermauert. Zu diesem Zweck wird 3,4,9,10-Perylentetracarbonsäuredianhydrid (PTCDA) gewählt, um Vergleichbarkeit der molekularen Filmstrukturen zu gewährleisten, und weil dessen elektronische Anordnung auf verschiedenen Metalloberflächen bereits eingehend untersucht worden ist. Wir weisen ionisiertes PTCDA an einigen dieser Grenzflächen nach und schlagen vor, dass der Ladungsübergang mit der elektronischen Niveauanpassung zusammenhängt, welche mit der Ausbildung von Grenzflächendipolen auf den entsprechenden Metallen einhergeht
Ouellet, Hugues. "Caractérisation biochimique et biophysique des hémoglobines 2/2 HbN et HbO de Mycobacterium tuberculosis." Thesis, Université Laval, 2009. http://www.theses.ulaval.ca/2009/26156/26156.pdf.
Full textTazay, Ahmad F. "Smart Inverter Control and Operation for Distributed Energy Resources." Scholar Commons, 2017. http://scholarcommons.usf.edu/etd/7097.
Full textOrtiz-Cuàran, Sandra. "Interactions between tumour suppressor p53 and HBV antigen HBx in liver carcinogenesis : molecular epidemiology and mechanistic studies." Thesis, Lyon 1, 2012. http://www.theses.fr/2012LYO10067.
Full textHepatocellular carcinoma (HCC) is the main form of primary liver cancer. HCC presents geographical variations in incidence that reflect variations in the prevalence of chronic infections by hepatitis B virus (HBV) and / or C (HCV) and dietary exposure to aflatoxins. In areas of high incidence, a specific mutation at codon 249 of TP53 gene is frequently detected in HCC and has been proposed as a molecular hallmark of aflatoxin exposure. The corresponding mutated protein p.R249S, interacts with the viral oncogene HBx, which modulates viral replication, proliferation and cell survival. HBX sequences are detectable in the genomic DNA of more than 80% of HBVrelated HCC. We investigated the associations of mutation R249S with the molecular characteristics of HBX and progression of HCC using specimens obtained in two case-control studies developed in Thailand and in The Gambia. Our results demonstrate (1) that the mutation R249S is preferentially associated with HCC that develop in the absence of pre-existing liver cirrhosis, (2) that the mutation is associated with the presence of polymorphisms in intron 1 of TP53, suggesting influence of genetic susceptibility factors on the formation of mutations, (3) that the mutation is usually associated with the retention of cancers with complete HBX sequences. These results suggest that the mutated protein p.R249S cooperates with HBx to promote the development of HCC without cirrhosis, and that susceptibility to the formation of this mutation is influenced by the polymorphic structure of TP53
Martins, Saulo. "Soroprevalência de marcadores da infecção pelo HBV e dos títulos de anti-HBs em indivíduos soropositivos para o HIV." reponame:Repositório Institucional da UFSC, 2014. https://repositorio.ufsc.br/xmlui/handle/123456789/128977.
Full textMade available in DSpace on 2015-02-05T20:33:26Z (GMT). No. of bitstreams: 1 327703.pdf: 3101411 bytes, checksum: f8c60d47a43ee28b03d37f24f32ff1f7 (MD5) Previous issue date: 2014
As infecções pelo HIV e pelo HBV são preocupantes problemas de saúde pública, sendo que, a infecção pelo HBV se constitui no principal problema mundial de saúde pública; estima-se que existam 350 milhões de portadores crônicos do HBV no mundo. No Brasil, a prevalência do HBV em geral é moderada (2% a 7%), com baixa taxa de infecção no Sul, média taxa de infecção no Nordeste e Sudeste e uma alta prevalência na região Amazônica, Espírito Santo e no oeste de Santa Catarina. O Brasil registrou 608.230 casos de AIDS desde 1980, o que representa uma prevalência média de 0.6% da população adulta. No início de 2014 poucos dados estão disponíveis sobre a prevalência dos marcadores de infecção e imunidade para hepatite B em indivíduos soropositivos para o HIV. Objetivos: Estabelecer a prevalência dos marcadores de infecção, de imunidade para o vírus da hepatite B e a cobertura vacinal contra HBV em indivíduos adultos HIV soropositivos confirmados residentes na região metropolitana de Florianópolis. População: Participaram deste estudo, realizado no período de outubro de 2012 a março de 2013, 300 voluntários, comprovadamente soropositivos para o HIV. Dados sócios demográficos como a idade, gênero, etnicidade, escolaridade, renda mensal, tempo do diagnóstico do HIV, tempo de terapia antirretroviral, forma mais provável da infecção pelo HIV e o resultados de carga viral do HIV e contagem de linfócitos T CD4, foram obtidos dos pacientes. Resultados: A prevalência dos marcadores HBsAg, anti-HBc foi de 2,3% e 29,3%, respectivamente. O marcador de imunidade anti-HBs, apresentou prevalência de 56,7% nos pacientes estudados; 43,3% dos pacientes estudados apresentavam título menor que 2,0 mUI/mL, em 9,7% o título estava entre 2,1 e 10,0 mUI/mL e em 47,0% o título era maior que 10,1 mUI/mL. A cobertura vacinal foi de 57,4%. Dos pacientes vacinados, se verificou que 15,3%, 7,7% e 34,3% apresentavam título de anti-HBs < 2,1 mUI/mL, de 2,1 a 10,0 mUI/mL e >10,1 mUI/mL, respectivamente. Conclusões: A prevalência dos marcadores HBsAg e anti-HBc apresentou uma redução expressiva, quando comparados aos resultados verificados em 1999, em estudo feito na mesma região e população alvo. A cobertura vacinal da população estudada, de 57,4% é significante, mas a disponibilidade da vacina pode ser ainda melhor divulgada e intensificada/ampliada pelo Ministério da Saúde.
Abstract : Introduction: HIV infection and HBV are two troubling public health problems, and that HBV infection is the main global public health problem, it is estimated that there are 350 million chronic carriers of HBV. In Brazil, the prevalence of HBV is generally moderate (2 % to 7 %), with low infection rate in the South, the average rate of infection in the Northeast and Southeast and a high prevalence in the Amazon, the Espírito Santo and the western region of Santa Catarina. There are in Brazil registered 608,230 cases of AIDS since 1980, representing an average prevalence of 0.6 % of the adult population. There are currently few data are available on the prevalence of markers of infection and immunity to hepatitis B in HIV-seropositive individuals. Objectives: To determine the prevalence of markers of infection, immunity to hepatitis B virus and HBV vaccination coverage in adults confirmed HIV seropositive residents in the metropolitan region of Florianópolis. Population: The study, was conducted from October 2012 to March 2013, 300 volunteers, proven HIV seropositive. Demographic social data such as age, gender, ethnicity, education, income, time of HIV diagnosis, duration of antiretroviral therapy, most likely form of HIV infection and the results of HIV viral load and CD4 counts were obtained from patients. Results: The prevalence of HBsAg, anti-HBc was 2.3% and 29.3%, respectively. The marker of immunity anti-HBs, showed a prevalence of 56.7% in the patients studied, 43.3% of patients had a lower title than 2.0mIU/mL, in 9.7% the title was between 2.1 and 10.0mIU/mL and 47.0% greater than the title was 10.1mIU/mL. Vaccination coverage was 57.4%. Of the vaccinated patients, it was found that 15.3%, 7.7% and 34.3% had a titer of anti-HBs < 2.1mIU/mL, 2.1 to 10.0mIU/ml and > 10.1mIU/mL, respectively. Conclusions: The prevalence of HBsAg and anti-HBc showed a significant reduction when compared to those recorded in 1999, in a study done in the same area and target population results. The vaccination coverage of the population studied, 57.4% is significant, but the availability of the vaccine may be even better publicized and intensified / amplified by the Brazilian Ministry of.
Shaikh, Mujaheed, and Afschin Gandjour. "Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two-step instrumental variables strategy." John Wiley & Sons Ltd, 2018. http://dx.doi.org/10.1002/hec.3832.
Full textDoležalová, Kateřina. "HBO." Master's thesis, Akademie múzických umění v Praze.Filmová a televizní fakulta. Knihovna, 2015. http://www.nusl.cz/ntk/nusl-251446.
Full textHolmes, Donna Leanne. "Old company records: The effect of custodial history on the arrangement and description of selected archival collections of business records." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2008. https://ro.ecu.edu.au/theses/23.
Full textNitsche, Robert. "Optical Properties of Organic Semiconductors: from Submonolayers to Crystalline Films." Doctoral thesis, [S.l.] : [s.n.], 2005. http://deposit.ddb.de/cgi-bin/dokserv?idn=979835186.
Full textNitsche, Robert. "Optical Properties of Organic Semiconductors: from Submonolayers to Crystalline Films." Doctoral thesis, Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2006. http://nbn-resolving.de/urn:nbn:de:swb:14-1147356837431-39487.
Full textMohammed, Essam Mohammed Ahmed. "The effect of APOBEC3 deaminases on HBV replication and the role of HBx in the inhibition of RNA interference and in the development of hepatocellular carcinoma." Thesis, Imperial College London, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.485554.
Full textAndrigueti, Michelle. "Soroprevalência de marcadores da infecção pelo HBV, dos títulos de anti-HBS e cobertura vacinal em crianças e adolescentes filhos de mães soropositivas para o HIV." reponame:Repositório Institucional da UFSC, 2016. https://repositorio.ufsc.br/xmlui/handle/123456789/168043.
Full textMade available in DSpace on 2016-09-20T04:47:43Z (GMT). No. of bitstreams: 1 340689.pdf: 1732443 bytes, checksum: e761e41bf16c7ac60e439fc76dfb9a08 (MD5) Previous issue date: 2016
Introdução: As infecções pelo vírus da hepatite B (HBV) e pelo vírus da imunodeficiência humana adquirida (HIV) são problemas mundiais de saúde pública. O HBV e o HIV partilham das mesmas vias de transmissão, o que torna bastante frequente a coinfecção por esses dois vírus. Crianças e adolescentes, filhos de mães soropositivas para o HIV apresentam elevado risco de contaminação também pelo HBV. O objetivo deste estudo foi estabelecer a prevalência dos marcadores de infecção e imunidade pelo vírus da hepatite B e a cobertura vacinal contra hepatite B em crianças e adolescentes, filhos de mães soropositivas para o HIV, atendidos no Hospital Infantil Joana de Gusmão, na cidade de Florianópolis, Santa Catarina. Métodos: o estudo foi realizado no período de janeiro a outubro de 2015, e participaram deste, 104 pacientes, com idade entre 0 e 15 anos, filhos de mães comprovadamente soropositivas para o HIV. Dados sóciodemográficos foram obtidos dos pacientes. Os marcadores da hepatite B, HBsAg, anti-HBc e anti-HBs foram realizadas através da metodologia de imunoensaio de micropartículas por quimioluminescência (CMIA), utilizando o equipamento ADVIA Centaur XP, e reagentes, controles e calibradores SIEMENS®. Resultados: Não se verificou prevalência dos marcadores HBsAg e anti-HBc total. O marcador de imunidade anti-HBs, apresentou prevalência de 59,6% nos pacientes estudados; 43,3% dos pacientes estudados apresentavam títulos iguais ou maiores que 10,0 mUI/mL, em 16,3% os títulos estavam entre 3,1 e 10,0 mUI/mL e em 40,4% o título foi menor que 3,1 mUI/mL. A cobertura vacinal foi de 70,58%. Conclusões: A prevalência dos marcadores HBsAg e anti-HBc total observada foi menor que os resultados verificados em 1999 e 2014, em estudos feitos na mesma região, tendo como população alvo os adultos infectados pelo HIV e crianças e adolescentes da população em geral. Considerando o que foi verificado nas carteiras de vacinação, a cobertura vacinal da população estudada, foi de 70,58%. Contudo, se considerarmos esta cobertura vacinal e o percentual de pacientes que apresentaram títulos de anti-HBs, mas não apresentaram carteira de vacinação, a cobertura pode ser estimada em 92,9%.
Abstract : Introduction: Infection with hepatitis B (HBV) virus and the human immunodeficiency virus (HIV) are global public health problems. HBV and HIV share the same transmission routes, making it common coinfection by these two viruses. For this reason, children and adolescents, born from HIV-positive mothers are at high risk also for HBV infection. The aim of this study was to determine the prevalence of infection and immunity markers of hepatitis B virus and the vaccine coverage against hepatitis B in children and adolescents, born from HIV-positive mothers, accepted at Joana de Gusmão Children's Hospital in the city of Florianópolis, Santa Catarina. Methods: The study was performed from January to October 2015, and 104 patients were enrolled, between 0 and 15 years of age, born from proven HIV-positive mothers. Demographic social data were collected from patients. The blood tests included HBsAg, Total anti-HBc and anti-HBs were performed by Chemiluminescence Microparticle Immunoassay by ADVIA Centaur XP SIEMENS®.Results: There was not prevalence of HBsAg and anti-HBc in this study. Marker of immunity anti-HBs had a prevalence of 59.6% in the studied patients; 43.3% of patients had equal or higher titers than 10.0 mIU/ml, in 16.3% of titers were between 3.1 and 10.0 mIU/mL and 40.4% titers was lower than 3.1 mIU / mL. Vaccination coverage was 70,58%.Conclusions: The prevalence of HBsAg and anti-HBc is lower than the results recorded in 1999 and 2014 in studies in the same area, targeting the HIV-infected adults population and children and adolescents of general population. Considering what was found in the vaccination record cards, vaccination coverage of the population studied was 70,58%. However, if we consider this vaccination coverage and the percentage of patients who had anti-HBs titles, but did not have vaccination records, this coverage could be estimated at 92.9%.
Sundaravadivel, Prabha. "Application-Specific Things Architectures for IoT-Based Smart Healthcare Solutions." Thesis, University of North Texas, 2018. https://digital.library.unt.edu/ark:/67531/metadc1157532/.
Full textRegiani, Anelise Maria. "Eletrólitos sólidos poliméricos à base de polissacarídeos: síntese e caracterização." Universidade de São Paulo, 2000. http://www.teses.usp.br/teses/disponiveis/75/75131/tde-18092001-165107/.
Full textThe synthesis and characterization of new types of solid polymer electrolytes based on hydroxyethyl and hydroxypropyl cellulose grafted with different polyethers were investigated. The synthesis is based on the reaction between the cellulose derivative and mono and difunctional isocyanates prepared from amines of polyethylene oxide and polypropylene oxide. It were also synthesized films of hydroxyethyl cellulose grafted with hexamethylene diisocyanate and phenylisocyanate. These materials were characterized through techniques of infrared, ultraviolet and nuclear magnetic ressonance spectroscopies, thermal analysis and X-ray diffraction. The films of polysaccharide and polyether that contained LiClO4 showed conductivity values of the order of 10-5 Scm-1 at 60oC. The value of this parameter seems to be independent of the cellulose derivative parameters and it is better related to the type of isocyanate grafted on the polysaccharide chain. The conductivity and chain mobility results show that the systems studied here can be applied as solid polymer electrolytes. The materials synthesized using commercial isocyanates as grafting reactant did not show interesting conductivity response.
Mouzannar, Karim. "Identification du récepteur nucléaire des acides biliaires FXR alpha comme facteur proviral pour le virus de l’hépatite B." Thesis, Lyon, 2018. http://www.theses.fr/2018LYSE1098/document.
Full textHepatitis B virus (HBV) infection is a major global health problem with more than 257 million chronic carriers worldwide that remain at significant risk for developing cirrhosis and/or hepatocellular carcinoma. The natural history of infection is very different depending on the age at which the infection is contracted. Whereas in adults most HBV infections spontaneously resolve, in infants and young children they usually result in chronic infection. cccDNA is the molecular form of viral persistence in infected hepatocytes and serves as a transcription template for all viral RNAs. The viral protein HBx plays a crucial role in the recruitment of epigenetic factors to the cccDNA and promotes its transcriptional activity. Currently, interferon and nucleot(s)ide analogues are the first-line agents in the treatment of chronic hepatitis B without allowing eradication of cccDNA and their interruption are almost always followed by a reactivation of the replication of the virus. New therapeutic molecules targeting cccDNA are therefore needed to hope for a functional cure in chronically infected patients. HBV infection and bile acid (BA) metabolism are tightly linked. Therefore, our team has previously shown that the bile acid nuclear receptor, the farnesoid X receptor alpha (FXRalpha) bind to two response elements present in the Enhancer II - Core promoter region of HBV genome and modulate its transcriptional activity. Moreover, HBV and BA compete for the same entry receptor of hepatocytes NTCP and modify BA cell concentration with consequences on the function and expression of FXRalpha. Finally, HBx interacts with FXRalpha and modify its activity. During my PhD. we have first identified a reciprocal regulation between HBV replication and FXRalpha. Second, we have showed in vitro, in HepaRG differentiated cells and in primary human hepatocytes, that FXRalpha is a proviral factor for HBV and that FXRalpha agonists inhibit the expression of all HBV markers in a dependent or independent manner of the viral protein HBx. Finally, in an in vivo model of C3H/HeN mice transduced with a recombinant AAV2/8-HBV vector, we obtained the inhibitory effect of FXRalpha agonists but only in adult and not in young mice. Considering the evolution of the gut flora with age and its importance in the metabolism of BA, these results suggest that the high rate of chronic progression in young children might be related to the immaturity of BA metabolism. The identification of a link between BA metabolism, gut microbiome composition and evolution of HBV infection will represent a big step toward the understanding of HBV natural history. Moreover, the identification of FXRalpha as a proviral factor for HBV and the capacity of FXRalpha ligands to modulate the transcriptional activity of cccDNA suggest that FXR ligands might represent a new class of molecules with the aim to obtain functional cure for HBV infected patients
Brubäcken, Pär. "Hbt i skolan : En undersökning av lärares arbete med hbt-frågor och heteronorm." Thesis, Umeå universitet, Institutionen för tillämpad utbildningsvetenskap, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-80529.
Full textChen, Dawei. "The role of HBD-2 and HBD-3 in human T cell development." Thesis, University of East London, 2016. http://roar.uel.ac.uk/5121/.
Full textWagner, Christian. "Potential Energy Minimization as the Driving Force for Order and Disorder in Organic Layers." Doctoral thesis, Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2010. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-38242.
Full textThema dieser Arbeit ist die strukturelle Charakterisierung von organischen Einfach- und Heterolagen sowie deren theoretische Beschreibung und Modellierung. Es wurden Submonolagen und Monolagen (ML) der polyzyklischen Kohlenwasserstoffe Quaterrylen (QT) und Hexa-peri-hexabenzocoronen (HBC) auf Ag(111) und Au(111) Einkristallen untersucht und ein Übergang von einer ungeordneten, isotropen Phase zu einer geordneten Phase mit steigender Bedeckung beobachtet. Die geordnete Phase wies dabei bedeckungsabhängige Gitterkonstanten auf. Das intermolekulare Potential wurde unter Berücksichtigung von Coulomb und van der Waals Anteilen mittels Kraftfeldmethoden modelliert. Der postulierte repulsive Charakter des Potentials konnte auf die Ladungsverteilung im Molekül und eine Abschwächung des van der Waals Potentials zurückgeführt werden. Weiterhin wurde der Einfluss der variablen HBC Gitterkonstante auf die epitaktische Relation des Gitters zum Metallsubstrat untersucht. Der zweite Teil der Arbeit widmet sich der Untersuchung einer ML 3,4,9,10-Perylenetetracarboxylic dianhydrid (PTCDA) auf einer ML HBC. Dabei wurden, in Abhängigkeit von der HBC Gitterkonstante, insgesamt drei verschiedene Typen von line-on-line bzw. point-on-line Epitaxie nachgewiesen. Im Anschluss an eine Analyse der generellen Eigenschaften solcher epitaktischer Lagen mittels Kraftfeldrechnungen wird eine neue Methode zur Vorhersage der Struktur konkreter Systeme vorgestellt
Schmidt, Sebastian [Verfasser], and Karl-Michael [Akademischer Betreuer] Weitzel. "Untersuchung der Ionen-Molekül-Systeme HBr+ (DBr+) + HBr sowie HBr+ + HCl (DCl) auf der Basis rotationszustandsselektierter Ionen / Sebastian Schmidt ; Betreuer: Karl-Michael Weitzel." Marburg : Philipps-Universität Marburg, 2021. http://d-nb.info/1239240007/34.
Full textStenback, Rachel Elisabeth. "H.C. Andersen : en etnologisk sagostudie." Thesis, Uppsala University, Department of Cultural Anthropology and Ethnology, 2001. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4710.
Full textBlücker, Lina, and Andrea Kindstrand. "HBT-certifiering av Sollentuna bibliotek." Thesis, Linnéuniversitetet, Institutionen för kulturvetenskaper (KV), 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-36397.
Full text